Postoperative Analgesic Effects of Bilateral External Oblique Intercostal Block in Laparoscopic Cholecystectomy Surgery

Pain, Postoperative Clinical Trial

Official title:

Post-operative Analgesic Effects of Bilateral External Oblique Intercostal Block in Laparoscopic Cholecystectomy Surgeries.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05444985
• Other study ID #: HATICE55
• Status: Completed
• Phase: N/A
• Start date: July 17, 2022
• Est. completion date: May 9, 2023

Study information

• Verified date: July 2023
• Source: Samsun University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of our study is to reduce postoperative pain by performing external oblique intercostal block in L/S cholecystectomy surgeries. Our main goal is to provide well managed post-operative analgesia.

Description:

The patients will be divided into two groups and general anesthesia will be applied to all of them. There will be no regional anesthetic technique to be performed, on the other hand, external oblique intercostal nerve block will be applied to patients in the other group before the patients are extubated. Study randomization is done with computer-generated randomization codes (computer-generated) by a physician who will not participate in patient follow-up. Interfascial plane block (external oblique intercostal block) will be given to the anesthesiologist in a sealed envelope by an independent assistant staff outside the study, the patient will not know which block is applied. The anesthetist who made the block will not participate in the pain follow-up of the patients. Postoperative pain assessment and data collection will be performed by another anesthetist blinded to the study.

For the standardization, the block procedure will be performed by an experienced anesthesiologist who has performed at least 20 previous successful and uncomplicated procedures.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 80
• Est. completion date: May 9, 2023
• Est. primary completion date: May 9, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• BMI < 35 kg/m²

• Patients with ASA scores I and II

Exclusion Criteria:

• Patients who do not want to be included in the study

• Psychiatric and neurological disease with blurred consciousness

• Patients with ASA > 3

• BMI > 35 kg/m²

• Abnormality in coagulation parameters

• History of allergy to local anesthetic drugs

• Infection at the injection site

Related Conditions & MeSH terms

• Analgesia
• Pain, Postoperative

Intervention

Other:
• Pain Management
Regional anesthetic techniques for peri-operative pain management after surgery.

Locations

Country	Name	City	State
Turkey	Samsun University	Samsun

Sponsors (1)

Lead Sponsor	Collaborator
Samsun University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative opioid consumption	Contramal consumption in the first 24 hours after surgery	24 hours
Secondary	NRS scores	NRS scores in the first 24 hours after surgery	At 1,3, 6, 12, 18, 24 hours
Secondary	Quality of recovery	QR15 scores	24 hours
Secondary	Nausea and vomiting	Nausea and vomiting scores in the first 24 hours	At 1,3, 6, 12, 18, 24 hours